Simplex Trading’s Calithera Biosciences, Inc CALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-430
Closed -$3K 11660
2022
Q1
$3K Buy
430
+60
+16% +$613 ﹤0.01% 9791
2021
Q4
$4K Buy
370
+105
+40% +$2.64K ﹤0.01% 9769
2021
Q3
$10K Hold
265
﹤0.01% 8966
2021
Q2
$11K Buy
265
+263
+13,150% +$11.6K ﹤0.01% 9072
2021
Q1
$11K Sell
2
-78
-98% -$4.54K ﹤0.01% 7864
2020
Q4
$788K Buy
+80
New +$7.01K ﹤0.01% 2852
2020
Q3
Sell
-4
Closed -$43K 8810
2020
Q2
$43K Sell
4
-5
-56% -$594 ﹤0.01% 5636
2020
Q1
$76K Sell
9
-5
-36% -$596 ﹤0.01% 4678
2019
Q4
$160K Buy
+14
New +$1.05K ﹤0.01% 3995
2019
Q3
Sell
-2
Closed -$160 6984
2019
Q2
$12K Sell
2
-9
-82% -$1.02K ﹤0.01% 6025
2019
Q1
$151K Buy
+11
New +$1.16K ﹤0.01% 3910
2018
Q3
Sell
-14
Closed -$138K 8329
2018
Q2
$138K Buy
14
+11
+367% +$1.25K ﹤0.01% 3916
2018
Q1
$8K Buy
3
+1
+50% +$156 ﹤0.01% 4266
2017
Q4
$9K Sell
2
-1
-33% -$256 ﹤0.01% 4037
2017
Q3
$13K Sell
3
-32
-91% -$10.1K ﹤0.01% 3569
2017
Q2
$19K Sell
35
-4
-10% -$1.07K ﹤0.01% 3366
2017
Q1
$72K Buy
+39
New +$6.74K ﹤0.01% 2036
2016
Q2
Sell
-2
Closed -$8K 6677
2016
Q1
$8K Buy
+2
New +$227 ﹤0.01% 3730
2015
Q3
Sell
-2
Closed -$3K 6418
2015
Q2
$3K Buy
+2
New +$464 ﹤0.01% 4143

Other funds holding CALA

Simplex Trading's CALA Position: Q2 2022 in Review

Simplex Trading sold out of Calithera Biosciences, Inc (CALA) in Q2 2022, closing a stake of 396 shares — an estimated $3K sold.

Simplex Trading first reported a position in CALA in Q2 2015 and held it in 18 quarters. The position peaked at $564K in Q2 2017. 28 funds tracked by Wall St. Rank hold CALA as of Q2 2022.

  • Simplex Trading reported no remaining Calithera Biosciences, Inc position as of Q2 2022 after selling out during the quarter.
  • Simplex Trading sold 396 Calithera Biosciences, Inc shares in Q2 2022, an estimated $3K.
  • Simplex Trading first reported a position in Calithera Biosciences, Inc in Q2 2015 and held it in 18 quarters.
  • Simplex Trading's Calithera Biosciences, Inc position peaked at $564K in Q2 2017.
  • 28 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2022.

Based on Simplex Trading's 13F filing for Q2 2022, filed 3 Aug 2022.